In the recent financial disclosure filed on February 10, 2025, Republican Congressman Jared Moskowitz from Florida's 23rd district reported a series of trades executed on January 15, 2025. The trades reflect a mix of buy and sell transactions, each valued between $1,001 and $15,000.

On the sell side, Moskowitz divested shares in several companies: Canadian National Railway Company (CNI), Abbott Laboratories (ABT), and Merck & Company, Inc. (MRK). Notably, the disclosure indicates repeated sales of both CNI and MRK stocks, suggesting a strategic reduction in these holdings.

Conversely, Moskowitz made purchases in other stocks, including the Goldman Sachs Group, Inc. (GS), Mckesson Corporation (MCK), and AbbVie Inc. (ABBV). The transactions in GS and MCK were repeated, indicating a potential strategic interest or confidence in these companies' prospects.

Overall, Moskowitz's trades reflect a reallocation of his portfolio, with a noticeable shift towards financial and pharmaceutical sectors, as evidenced by the acquisitions of GS, MCK, and ABBV stocks.